InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-10.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Mahoney Stephen F., Autre. Director active across 2 companies, notably Magenta Therapeutics, Inc.. Aggregated, 6 filings have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €479k. Activity tracked since 14 September 2021. The latest transaction was disclosed on 3 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mahoney Stephen F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
7,408 股@ US$30.1930.0% 占其流量Common StockSEC:0001193125-26-099007:0
18,357 股Common StockSEC:0001193125-26-092036:0
21,400 股@ US$23.33100.0% 占其流量Common StockSEC:0000950170-24-110484:0
标准退出：2024年12月26日 (T+90)
3,000 股@ US$0.944.0% 占其流量Common StockSEC:0000899243-22-037433:0
5,736 股@ US$6.7392.3% 占其流量Common StockSEC:0000899243-21-036601:0
20,000 股0Common StockSEC:0000899243-21-036337:0
6 条申报中的 6 条
About Mahoney Stephen F.
Stephen F. Mahoney is associated with Magenta Therapeutics, Inc. Although his specific role is not detailed, he contributes to the company's mission in the biotechnology field. His experience and skills are an asset to the organization, helping to guide its initiatives and projects.
